Novo’s GLP-1 drug liraglutide slows cognitive decline by 18% in mid-stage Alzheimer's study - FirstWord Pharma
- Novo’s GLP-1 drug liraglutide slows cognitive decline by 18% in mid-stage Alzheimer's study FirstWord Pharma
- Weight-loss drug could help slow Alzheimer’s cognitive decline, trial finds The Guardian
- Weight loss jabs slow progress of Alzheimer’s, study suggests The Telegraph
- Weight-loss drug ‘could slow progression of Alzheimer’s disease’ The Independent